Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (466)

1

Calculate incidence rates of BNT162b2-related arterial or venous thrombosis only from the entire cohort of interest

enthalten in: Thrombosis research | 2024

von Finsterer, J.

2

Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis : analysis of a prospective cohort

enthalten in: Clinical and experimental rheumatology | 2024

von Bartoletti, A. | Fornara, C. | Delvino, P. | +5

3

Ulcerating reaction in association with Pfizer-BioNTech COVID-19 vaccine in an 11-year-old boy

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Thrush, J. | Polly, S. | Anthony, J. | +4

4

Mondor's disease following the third dose of BNT162b2 m-RNA COVID-19 vaccine

enthalten in: International journal of dermatology | 2024

von Drago, F. | Cittadini, G. | Garlaschi, A. | +1

5

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years : Author's reply to correspondence

enthalten in: Human vaccines & immunotherapeutics | 2023

von Ripabelli, G. | Salzo, A. | Tamburro, M.

CommentOn: Hum Vaccin Immunother. 2022 Nov 30;18(6):2126668. - PMID 36315849

6

Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection

enthalten in: Emerging microbes & infections | 2023

von Bingula, R. | Chabrolles, H. | Bonnet, B. | +11

7

Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine

enthalten in: European journal of clinical investigation | 2023

von Schmeling, M. | Manniche, V. | Hansen, P.

CommentOn: Eur J Clin Invest. 2023 Aug;53(8):e13998. - PMID 36997290

8

Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years

enthalten in: The Journal of clinical investigation | 2023

von Strumann, C. | Ranzani, O. | Moor, J. | +4

9

Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination

enthalten in: The Journal of infection | 2023

von Varasi, I. | Lai, A. | Fiaschi, L. | +10

10

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine

enthalten in: Singapore medical journal | 2023

von Tay, C. | Lai, D.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[47]